Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_assertion type Assertion NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_head.
- NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_provenance.
- NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_assertion evidence source_evidence_literature NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_provenance.
- NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_assertion SIO_000772 21726203 NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_provenance.
- NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_assertion wasDerivedFrom befree-20140225 NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_provenance.
- NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_assertion wasGeneratedBy ECO_0000203 NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_provenance.